Cy5.5 NHS Ester (Non-Sulfonated): Optimizing Near-Infrared Fluorescent Labeling for Molecular Imaging

Principle and Setup: Why Cy5.5 NHS Ester (Non-Sulfonated) Leads in Molecular Imaging

The Cy5.5 NHS ester (non-sulfonated), available from APExBIO, is a state-of-the-art near-infrared fluorescent dye for biomolecule labeling. Its core utility lies in the NHS (N-hydroxysuccinimide) ester functional group, which reacts specifically and efficiently with primary amines—prevalent on lysine residues of proteins, N-termini of peptides, and amino-modified oligonucleotides—to form stable amide bonds. This enables the creation of highly photostable, covalently-linked conjugates, essential for reproducibility in fluorescence-based molecular biology and imaging workflows.

With an excitation maximum at 684 nm and emission at 710 nm (Cy5.5 excitation/emission), Cy5.5 NHS ester penetrates the near-infrared (NIR) spectral region. This zone offers greatly reduced background autofluorescence, minimal light scattering, and deeper tissue penetration compared to visible-range dyes. These properties are pivotal for advanced in vivo fluorescence imaging, especially for tracking cellular processes, imaging tumors, and studying tissue-level phenomena in real time. Furthermore, the non-sulfonated structure ensures high labeling efficiency and hydrophobic character, beneficial for applications that do not require additional aqueous solubility.

Key features at a glance:

• Labeling specificity: Selective for amino group labeling via robust NHS ester chemistry.
• Excitation/emission: 684/710 nm—optimal for deep-tissue optical imaging of tumors and in vivo models.
• Solubility: ≥35.82 mg/mL in DMSO; low aqueous solubility, requiring organic co-solvent use.
• Stability: Solid form stable for 24 months at -20°C; labile in solution—prepare fresh before use.

Experimental Workflow: Step-by-Step Protocol and Enhancements

1. Preparation of Dye Stock Solution

• Weigh Cy5.5 NHS ester (non-sulfonated) (SKU: A8103) under low light to minimize photobleaching.
• Dissolve in anhydrous DMSO or DMF to a stock concentration (e.g., 10 mM). The dye is highly soluble in DMSO—ensure ≥35.82 mg/mL for maximum flexibility in labeling reactions.
• Avoid repeated freeze-thaw cycles; aliquot under inert gas (argon or nitrogen) if possible.

2. Biomolecule Preparation

• Desalt and buffer-exchange your protein, peptide, or amino-modified oligonucleotide into a labeling buffer (commonly 0.1 M sodium bicarbonate, pH 8.3). Avoid primary amine-containing buffers (e.g., Tris, glycine) as they compete for NHS ester reactivity.
• Optimal concentration: ≥1 mg/mL for proteins; ≥50 µM for oligonucleotides.

3. Conjugation Reaction

• Add dye stock to biomolecule at a recommended molar ratio (typically 3–10:1 dye:biomolecule for proteins).
• Reaction volume: keep DMSO ≤10% v/v in the final mixture to prevent biomolecule denaturation.
• Incubate at room temperature for 30–60 minutes, protected from light.

4. Purification and Quality Control

• Remove unreacted dye via size-exclusion chromatography, desalting columns, or repeated ultrafiltration (MWCO appropriate for biomolecule size).
• Quantify labeling efficiency using absorbance at 684 nm (ε = 250,000 M^-1cm^-1 for Cy5.5) and calculate the degree of labeling (DOL).

5. Storage and Handling

• Store labeled conjugates at 4°C in the dark, with 0.02% sodium azide as a preservative if long-term storage is needed.
• Avoid repeated freeze-thaw cycles to preserve fluorescence and biological activity.

Advanced Applications and Comparative Advantages

Cy5.5 NHS ester (non-sulfonated) is widely adopted for both fluorescent dye for protein conjugation and nucleic acid labeling, but its real distinction emerges in advanced applications:

• In vivo fluorescence imaging: Its NIR emission enables sensitive detection of labeled biomolecules in live animal models, with minimal tissue autofluorescence. In tumor-bearing murine models, Cy5.5-labeled antibodies have delineated tumor margins with high contrast, supporting applications as a tumor imaging agent and for optical imaging of tumors.
• Neuromodulation studies: In pioneering work, ultrasound-triggered piezo-nanoplatforms used Cy5.5 NHS ester for non-invasive tracking of nanomaterial biodistribution and efficacy in epilepsy models (Li et al., 2025). The dye’s deep-tissue imaging capacity enabled real-time monitoring of nanoplatform localization and functional response, outperforming visible-spectrum labels.
• Molecular biology and cytometry: Flow cytometry, immunofluorescence, and in situ hybridization benefit from Cy5.5’s narrow emission and compatibility with multiplexed panels, reducing spectral overlap and enabling precise quantification.

For further protocol specifics, this fact-driven overview complements the core technical procedures above, while this resource expands on cell-based and cytotoxicity assay optimization using Cy5.5 NHS ester. For a broader translational context, the comprehensive blueprint contrasts Cy5.5 NHS ester’s unique deep-tissue imaging capabilities against alternative dyes, highlighting its role in next-generation molecular imaging.

Compared to sulfonated versions or traditional visible dyes (e.g., Cy3, Alexa Fluor 488), Cy5.5 NHS ester (non-sulfonated):

• Enables superior imaging depth (up to several centimeters in tissue) and signal-to-noise ratios in whole-animal studies.
• Exhibits higher photostability and reduced background, critical for longitudinal and high-throughput imaging workflows.
• Offers flexibility for conjugation to a wide range of biomolecules without altering their functional properties.

Troubleshooting and Optimization: Maximizing Labeling Success

Common Challenges and Solutions

1. Low Labeling Efficiency
   • Potential causes: Competing amines in buffer, suboptimal pH, hydrolyzed NHS ester, insufficient reaction time.
   • Solutions: Use amine-free buffers (avoid Tris/glycine); maintain pH 8.0–8.5; dissolve dye fresh; increase dye:biomolecule ratio or incubation time if necessary.
2. Precipitation or Aggregation
   • Potential causes: Excess dye or organic solvent, protein instability, poor mixing.
   • Solutions: Limit DMSO/DMF to ≤10% v/v; titrate dye addition; pre-filter solutions; optimize protein concentration.
3. High Background Fluorescence
   • Potential causes: Incomplete removal of free dye, autofluorescence from sample matrix.
   • Solutions: Thorough purification (size-exclusion or desalting columns); include appropriate control samples; use NIR-compatible filters during imaging.
4. Dye Degradation/Photobleaching
   • Potential causes: Prolonged light exposure, repeated freeze-thaw cycles, storage in solution.
   • Solutions: Minimize light exposure; store conjugates protected from light at 4°C; prepare dye solutions immediately before use.

Additional guidance, including validated protocols and safety considerations, is provided in scenario-driven troubleshooting articles—ideal for optimizing cell assays and protein labeling with Cy5.5 NHS ester.

Future Outlook: Next-Generation Imaging and Translational Impact

The integration of Cy5.5 NHS ester (non-sulfonated) into translational research and clinical diagnostics is accelerating. As demonstrated in the landmark ultrasound-triggered piezo-nanoplatform study, this dye is pivotal for non-invasive, real-time monitoring of therapeutic delivery and functional outcomes. Its capacity for near-infrared fluorescence imaging positions it as a cornerstone for emerging fields such as:

• Personalized oncology: Real-time tumor mapping and margin assessment during surgery.
• Neuroengineering: Non-invasive tracking of neuromodulatory nanoplatforms for disorders like epilepsy and beyond.
• Multiplexed biomarker detection: Expansion into panels for simultaneous quantification of multiple targets in tissue sections and live models.

According to recent thought-leadership analysis, Cy5.5 NHS ester is driving innovation at the interface of oncology, immunology, and microbiome research, validating its role as more than just a labeling reagent, but as a catalyst for high-impact, next-generation science.

Conclusion: Why Choose Cy5.5 NHS Ester from APExBIO?

Cy5.5 NHS ester (non-sulfonated) provides unmatched flexibility, sensitivity, and reliability for fluorescent labeling in molecular biology, in vivo imaging, and translational research applications. Its NIR properties, robust amide bond formation, and compatibility with advanced imaging platforms make it the reagent of choice for both established and emerging workflows. For researchers seeking validated, reproducible, and scalable solutions, APExBIO’s Cy5.5 NHS ester (non-sulfonated) is a trusted partner in scientific innovation.